Junyao Health

Junyao Health, a subsidiary of the JuneYao Group, is a prominent Chinese enterprise that has transitioned from a traditional beverage manufacturer into a technology-driven health and probiotics biotech company. The company specializes in the research, development, and commercialization of functional probiotic strains designed to address specific health concerns such as Helicobacter pylori infection, alcohol metabolism, and weight management. Through a long-term strategic partnership with Jiangnan University, Junyao Health utilizes a proprietary library of probiotic strains to produce both functional food products and specialized supplements. Its portfolio includes the well-known 'Wei-Li' lactic acid bacteria drinks as well as newer, high-value probiotic powders and tablets. Publicly traded on the Shanghai Stock Exchange, the company is increasingly focusing on 'biotech-grade' probiotics to lead the domestic functional nutrition market.